Recurrence of nonalcoholic steatohepatitis (NASH) post-liver transplantation
β Scribed by McCaughan, G W
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1997
- Tongue
- English
- Weight
- 17 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1074-3022
No coin nor oath required. For personal study only.
β¦ Synopsis
I read with interest the two case reports 1,2 and editorial 3 on recurrence of nonalcoholic steatohepatitis (NASH) post-liver transplantation. Many of the interesting points were well made. However, I was amazed that there was no discussion about the possibility that neither of the 2 patients actually required liver transplantation in the first place.
Cirrhosis in NASH is well recognized, but liver failure is extremely uncommon. 4 It seems clear in the first case that liver failure was not present at the time of transplantation, and in the second, details of liver function before transplantation are not given. If recurrence of NASH is a common problem, perhaps a major lesson from the two cases is that stricter guidelines for indications for transplantation should be thought about in this disease.
π SIMILAR VOLUMES
Nonalcoholic steatohepatitis (NASH) may progress to cirrhosis and lead to liver failure. Histologically, NASH is often indistinguishable from liver disease caused by alcohol use; the cause of NASH remains unknown. A subgroup of patients with NASH eventually develops fibrosis and/or cirrhosis, and in
A 42-year-old white man with morbid obesity and hypertriglyceridemia was noted to have nonalcoholic steatohepatitis (NASH) at the time of a laparoscopic cholecystectomy for presumed gallstone pancreatitis. His postoperative course was complicated by a 50-kg weight loss and continued right upper quad
Recurrence of the original disease following liver transplantation is not uncommon and can lead to graft failure. There are limited data on recurrent fatty liver disease following liver transplantation. The aim of this study was to determine the incidence of recurrent fatty liver disease in patients
Familial hypobetalipoproteinemia (FHBL) is one of the causes of nonalcoholic steatohepatitis (NASH) and a codominant disorder. Patients heterozygous for FHBL may be asymptomatic, although they demonstrate low plasma levels of low-density lipoprotein (LDL) cholesterol and apolipoprotein B. Here we re